OMEICOS Therapeutics
Total Raised
$39.1MInvestors Count
11Deal Terms
2Funding, Valuation & Revenue
8 Fundings
OMEICOS Therapeutics has raised $39.1M over 8 rounds.
OMEICOS Therapeutics's latest funding round was a Series C for $19.42M on November 2, 2018.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
11/2/2018 | Series C | $19.42M | Falck Group, Forbion, High-Tech Gruenderfonds, KfW, Remiges Ventures, SMS Group, VC Fonds Technologie, and Vesalius BioCapital | 1 | ||
10/4/2017 | Series B - II | |||||
6/8/2017 | Grant - III | |||||
3/1/2017 | Series B | |||||
11/2/2015 | Grant - II |
Date | 11/2/2018 | 10/4/2017 | 6/8/2017 | 3/1/2017 | 11/2/2015 |
|---|---|---|---|---|---|
Round | Series C | Series B - II | Grant - III | Series B | Grant - II |
Amount | $19.42M | ||||
Investors | Falck Group, Forbion, High-Tech Gruenderfonds, KfW, Remiges Ventures, SMS Group, VC Fonds Technologie, and Vesalius BioCapital | ||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
OMEICOS Therapeutics Deal Terms
2 Deal Terms
OMEICOS Therapeutics's deal structure is available for 2 funding rounds, including their Series B from March 01, 2017.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
OMEICOS Therapeutics Investors
11 Investors
OMEICOS Therapeutics has 11 investors. High-Tech Gruenderfonds invested in OMEICOS Therapeutics's Series C funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
4/15/2015 | 11/2/2018 | 4 Series A, Series B (2017), Series B - II (2017), Series C (2018) | Venture Capital | Germany | ||
4/15/2015 | 11/2/2018 | 4 Series A, Series B (2017), Series B - II (2017), Series C (2018) | Diversified Financial Services | Germany | ||
4/15/2015 | 11/2/2018 | 4 Series A, Series B (2017), Series B - II (2017), Series C (2018) | Venture Capital | Germany | ||
Corporation | Germany | |||||
Venture Capital | Luxembourg |
First funding | 4/15/2015 | 4/15/2015 | 4/15/2015 | ||
|---|---|---|---|---|---|
Last Funding | 11/2/2018 | 11/2/2018 | 11/2/2018 | ||
Investor | |||||
Rounds | 4 Series A, Series B (2017), Series B - II (2017), Series C (2018) | 4 Series A, Series B (2017), Series B - II (2017), Series C (2018) | 4 Series A, Series B (2017), Series B - II (2017), Series C (2018) | ||
Board Seats | |||||
Type | Venture Capital | Diversified Financial Services | Venture Capital | Corporation | Venture Capital |
Location | Germany | Germany | Germany | Germany | Luxembourg |
Loading...